Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.
Gramegna A, Misuraca S, Lombardi A, Premuda C, Barone I, Ori M, Amati F, Retucci M, Nazzari E, Alicandro G, Ferrarese M, Codecasa L, Bandera A, Aliberti S, Daccò V, Blasi F. Gramegna A, et al. Among authors: dacco v. Respir Res. 2023 Dec 16;24(1):316. doi: 10.1186/s12931-023-02612-1. Respir Res. 2023. PMID: 38104098 Free PMC article. Review.
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.
Colombo C, Alicandro G, Daccó V, Gagliano V, Morlacchi LC, Casciaro R, Pisi G, Francalanci M, Badolato R, Bignamini E, Messore B, Lucanto MC, Leonetti G, Maschio M, Cipolli M; Italian Cystic Fibrosis Society (SIFC) Study Group for COVID-19. Colombo C, et al. Among authors: dacco v. PLoS One. 2021 May 13;16(5):e0251527. doi: 10.1371/journal.pone.0251527. eCollection 2021. PLoS One. 2021. PMID: 33984027 Free PMC article.
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
Colombo C, Cipolli M, Daccò V, Medino P, Alghisi F, Ambroni M, Badolato R, Battistini F, Bignamini E, Casciaro R, Ciciriello F, Collura M, Comello I, Francalanci M, Ficili F, Folino A, Leonardi S, Leonetti G, Lucanto MC, Lucca F, Maschio M, Mencarini V, Messore B, Pisi G, Pizzamiglio G, Poli P, Raia V, Riberi L, Ros M, Rotolo N, Sepe A, Taccetti G, Vitullo P, Alicandro G. Colombo C, et al. Among authors: dacco v. Infection. 2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7. Infection. 2022. PMID: 34874541 Free PMC article.
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy.
Alicandro G, Daccó V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, Sciarrabba CS, Ferraro F, Orena BS, Gramegna A, Blasi F, Colombo C. Alicandro G, et al. Among authors: dacco v. J Cyst Fibros. 2022 Mar;21(2):e113-e116. doi: 10.1016/j.jcf.2021.12.011. Epub 2021 Dec 13. J Cyst Fibros. 2022. PMID: 34949558 Free PMC article.
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.
Alicandro G, Daccó V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, Sciarrabba CS, Ferraro F, Lanfranchi C, Orena BS, Gramegna A, Blasi F, Colombo C. Alicandro G, et al. Among authors: dacco v. J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16. J Cyst Fibros. 2022. PMID: 35256306 Free PMC article. No abstract available.
63 results